SS Innovations InternationalSSII +0.26%41 Equity-to-Asset is 0.60 as of Mar. 2026, which is 567% above its 10-year median of 0.09. GuruFocus rates SSII with a GF Score™ of 41/100 and a GF Value™ of $18.76 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, SS Innovations International ranks worse than 55.32% on this metric.
The historical rank and industry rank for SS Innovations International's Equity-to-Asset or its related term are showing as below:
SSII'
s Equity-to-Asset Range Over the Past 10 Years
Min: -25.4 Med: 0.09 Max: 0.77
Current: 0.6
During the past 10 years, the highest Equity to Asset Ratio of SS Innovations International was 0.77. The lowest was -25.40. And the median was 0.09.
SSII's Equity-to-Asset is ranked worse than 55.32% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs SSII: 0.60
SS Innovations International (NAS:SSII) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
SS Innovations International Equity-to-Asset Related Terms
SS Innovations International Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SS Innovations International Equity-to-Asset Chart
SSII vs BVS, TCMD, BBNX: Equity-to-Asset Comparison
For the Medical Devices subindustry, SS Innovations International's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SS Innovations International Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where SS Innovations International's Equity-to-Asset falls into.
SS Innovations International Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
SS Innovations International's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SS Innovations International (SSII) has a Equity-to-Asset of 0.60 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on SS Innovations International and its competitors. This is 567% above median its historical median of 0.09. According to the industry distribution chart, SS Innovations International ranks #473 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 55.3%.
Is SS Innovations International's Equity-to-Asset too high?
SS Innovations International's current Equity-to-Asset of 0.60 is 567% above median its 10-year median of 0.09. The Medical Devices & Instruments industry median Equity-to-Asset is 0.65. SS Innovations International's value of 0.60 is 7.7% below this industry median. Based on the distribution chart, SS Innovations International ranks #473 out of 855 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SS Innovations International has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SS Innovations International's Equity-to-Asset compare to BVS and TCMD?
According to the Medical Devices & Instruments industry distribution chart, SS Innovations International ranks #473 out of 855 companies for Equity-to-Asset. This places SS Innovations International in the lower half of its industry. The industry median Equity-to-Asset is 0.65. SS Innovations International's value of 0.60 is 7.7% below this benchmark. While the company's 10-year median is 0.09 vs. the industry median of 0.65, SS Innovations International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.65, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SS Innovations International's current Equity-to-Asset of 0.60 is 7.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on SS Innovations International and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SS Innovations International's current Equity-to-Asset is 0.60, which is 567% above median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SS Innovations International stock overvalued right now?
Based on GuruFocus' analysis, SS Innovations International (SSII) is currently considered Possible Value Trap. The stock's GF Value™ is $18.76, compared to a current price of $3.74 — trading 80.1% below its estimated fair value. The current Equity-to-Asset is 0.60, which is 567% above median its 10-year median of 0.09 and 7.7% below the Medical Devices & Instruments industry median of 0.65. SS Innovations International's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For SS Innovations International (SSII), the current Equity-to-Asset is 0.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SS Innovations International (SSII) Overvalued in 2026?
Based on GuruFocus' analysis, SS Innovations International stock appears to be undervalued.
The current stock price of $3.74 is trading 80.1% below its estimated GF Value™ of $18.76.
GuruFocus considers SS Innovations International to be Possible Value Trap.
Key valuation signals for SSII:
Equity-to-Asset: 0.60 (567% above median its 10-year median of 0.09)
GF Value™: $18.76 vs. price of $3.74 (80.1% below fair value)
Industry Position: 7.7% below the Medical Devices & Instruments median (#473 of 855)
No single metric tells the full story. See the SSII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
41GF Score
Get the complete analysis for SSII
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSII has been successfully added to your 
